 |
|
Monitoring globotriaosylsphingosine in a Korean male patient with Fabry disease
Heejoon Jang, Kwon Wook Joo, Seung Seok Han
Kidney Res Clin Pract. 2019;38(2):250-252. Published online 2019 Jun 30 DOI: https://doi.org/10.23876/j.krcp.18.0156
|
|
Citations to this article as recorded by
 A questionnaire survey on the diagnosis and treatment of Fabry nephropathy in clinical practice
Soo Jeong Choi, Su Hyun Kim, Min Sung Lee, Samel Park, Eunjung Cho, Seung Seok Han, Eun Sil Koh, Byung Ha Chung, Kyung Hwan Jeong, EunHui Bae, Eun Young Lee, Young Joo Kwon
Kidney Research and Clinical Practice.2023; 42(5): 628. CrossRef An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease
Dominique P. Germain, Gheona Altarescu, Roberto Barriales-Villa, Renzo Mignani, Krzysztof Pawlaczyk, Federico Pieruzzi, Wim Terryn, Bojan Vujkovac, Alberto Ortiz
Molecular Genetics and Metabolism.2022; 137(1-2): 49. CrossRef Human-induced pluripotent stem cell lines (CMCi006-A and CMCi007-A) from a female and male patient with Fabry disease carrying the same frameshift deletion mutation
Sheng Cui, Yoo Jin Shin, Eun Jeong Ko, Sun Woo Lim, Ji Hyeon Ju, Kang In Lee, Jae Young Lee, Chul Woo Yang, Byung Ha Chung
Stem Cell Research.2021; 51: 102214. CrossRef RIPK3 Contributes to Lyso-Gb3-Induced Podocyte Death
So-Young Kim, Samel Park, Seong-Woo Lee, Ji-Hye Lee, Eun Soo Lee, Miri Kim, Youngjo Kim, Jeong Suk Kang, Choon Hee Chung, Jong-Seok Moon, Eun Young Lee
Cells.2021; 10(2): 245. CrossRef Fabry nephropathy before and after enzyme replacement therapy: important role of renal biopsy in patients with Fabry disease
Il Young Kim, Hyun Jung Lee, Chong Kun Cheon
Kidney Research and Clinical Practice.2021; 40(4): 611. CrossRef
|